OCUL Competitors & Alternatives
Compare Ocular Therapeutix Inc with similar stocks in the same industry
Biotechnology
OCUL
Main Stock$10.49
Tradestie Score
51
Market Cap
$1.92B
Revenue Growth
0.0%
Analyst Upside
+158.3%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TARS
Tarsus Pharmaceuticals, Inc. Common Stock
|
$79.31
|
$2.42B | - | 37 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$173.79
|
$2.41B | - | 35 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$37.59
|
$2.40B | - | 45 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 52 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$23.89
|
$2.37B | 106.3 | 53 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$135.07
|
$2.35B | - | 54 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.91
|
$2.34B | - | 40 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$70.06
|
$2.33B | - | 53 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$33.60
|
$2.33B | - | 47 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 46 | Compare |
More OCUL Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
235 stocks in this industry